KR20040054692A - 17-알릴 아미노 겔다나마이신 (17-ａａｇ) 및 기타안사마이신의 제조 방법 - Google Patents

17-알릴 아미노 겔다나마이신 (17-ａａｇ) 및 기타안사마이신의 제조 방법 Download PDF

Info

Publication number
KR20040054692A
KR20040054692A KR10-2004-7004202A KR20047004202A KR20040054692A KR 20040054692 A KR20040054692 A KR 20040054692A KR 20047004202 A KR20047004202 A KR 20047004202A KR 20040054692 A KR20040054692 A KR 20040054692A
Authority
KR
South Korea
Prior art keywords
aag
protic solvent
ansamycin
volatile
melting point
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR10-2004-7004202A
Other languages
English (en)
Korean (ko)
Inventor
장린
뵘마커스에프
제가시애드
Original Assignee
콘포마 세러퓨틱스 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 콘포마 세러퓨틱스 코포레이션 filed Critical 콘포마 세러퓨틱스 코포레이션
Publication of KR20040054692A publication Critical patent/KR20040054692A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
KR10-2004-7004202A 2001-09-24 2002-09-18 17-알릴 아미노 겔다나마이신 (17-ａａｇ) 및 기타안사마이신의 제조 방법 Ceased KR20040054692A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US32663901P 2001-09-24 2001-09-24
US60/326,639 2001-09-24
US33189301P 2001-11-21 2001-11-21
US60/331,893 2001-11-21
PCT/US2002/029715 WO2003026571A2 (en) 2001-09-24 2002-09-18 Process for preparing 17-allyl amino geldanamycin (17-aag) and other ansamycins

Publications (1)

Publication Number Publication Date
KR20040054692A true KR20040054692A (ko) 2004-06-25

Family

ID=26985493

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2004-7004202A Ceased KR20040054692A (ko) 2001-09-24 2002-09-18 17-알릴 아미노 겔다나마이신 (17-ａａｇ) 및 기타안사마이신의 제조 방법

Country Status (9)

Country Link
US (1) US7579462B2 (https=)
EP (1) EP1435939B1 (https=)
JP (1) JP2005504086A (https=)
KR (1) KR20040054692A (https=)
CN (1) CN100378079C (https=)
AT (1) ATE387198T1 (https=)
CA (1) CA2460498A1 (https=)
DE (1) DE60225307T2 (https=)
WO (1) WO2003026571A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100796637B1 (ko) * 2006-09-29 2008-01-22 한국생명공학연구원 젤다나마이신 유도체, 이의 약학적으로 허용가능한 염,이의 제조방법 및 이를 유효성분으로 함유하는 암 예방 및치료제

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872715B2 (en) 2001-08-06 2005-03-29 Kosan Biosciences, Inc. Benzoquinone ansamycins
EP1435939B1 (en) 2001-09-24 2008-02-27 Conforma Therapeutic Corporation Process for preparing 17-allyl amino geldanamycin (17-aag) and other ansamycins
US7241890B2 (en) 2001-10-30 2007-07-10 Conforma Therapeutics Corporation Purine analogs having HSP90-inhibiting activity
EP1472230B1 (en) 2002-02-08 2009-06-17 Conforma Therapeutic Corporation Ansamycins having improved pharmacological and biological properties
KR20060070572A (ko) 2003-09-18 2006-06-23 콘포마 세러퓨틱스 코포레이션 Ｈｓｐ90-저해제로서의 신규 헤테로시클릭 화합물
BRPI0418147A (pt) 2003-12-23 2007-04-17 Infinity Pharmaceuticals Inc análogos de ansamicinas contendo benzoquinona e seus métodos de uso
KR101045324B1 (ko) * 2004-08-11 2011-06-30 한국생명공학연구원 젤다나마이신 유도체 및 그 생합성 방법
US7371906B2 (en) 2004-08-24 2008-05-13 Eastman Kodak Company Process for photo-oxidative stability improvements
CN105879114A (zh) * 2005-02-18 2016-08-24 阿布拉西斯生物科学公司 用于整合入医疗装置的疏水性改善的药物
CA2602257A1 (en) 2005-03-30 2006-10-05 Conforma Therapeutics Corporation Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors
BRPI0608661A2 (pt) * 2005-04-07 2010-01-19 Conforma Therapeutics Corp formulaÇço farmacÊutica, uso de formulaÇço farmacÊutica, e, mÉtodo de preparaÇço de uma formulaÇço farmacÊutica
US7648976B2 (en) * 2005-11-23 2010-01-19 Bristol-Myers Squibb Company 17-allylamino-17-demethoxygeldanamycin polymorphs and formulations
US20090042847A1 (en) * 2005-11-23 2009-02-12 Kosan Biosciences Incorporated 17-allylamino-17-demethoxygeldanamycin polymorphs and formulations
JP2009518302A (ja) * 2005-12-01 2009-05-07 コンフォーマ・セラピューティクス・コーポレイション アンサマイシン含有組成物
JP5528807B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
WO2008044041A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
PE20081506A1 (es) * 2006-12-12 2008-12-09 Infinity Discovery Inc Formulaciones de ansamicina
KR100861697B1 (ko) * 2007-01-30 2008-10-07 한국생명공학연구원 Ａｈｂａ 생합성 유전자 변이주를 이용한 안사마이신유도체의 생산 방법 및 신규한 안사마이신 유도체
WO2010045442A1 (en) 2008-10-15 2010-04-22 Infinity Discovery, Inc. Ansamycin hydroquinone compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3595955A (en) * 1969-03-26 1971-07-27 Upjohn Co Geldanamycin and process for producing same
US4261989A (en) * 1979-02-19 1981-04-14 Kaken Chemical Co. Ltd. Geldanamycin derivatives and antitumor drug
FI943207A0 (fi) 1992-01-06 1994-07-05 Pfizer 4,5-dihydrogeldanamysiinin ja sen hydrokinonin valmistusmenetelmä ja käyttö
US5387584A (en) 1993-04-07 1995-02-07 Pfizer Inc. Bicyclic ansamycins
CA2166320A1 (en) 1993-06-29 1995-01-12 Randall James Gallaschun Ansamycin derivatives as antioncogene and anticancer agents
US5932566A (en) * 1994-06-16 1999-08-03 Pfizer Inc. Ansamycin derivatives as antioncogene and anticancer agents
US5883236A (en) * 1997-11-19 1999-03-16 Abbott Laboratories Process for N-desmethylating erythromycins and derivatives thereof
WO2000061578A1 (en) 1999-04-09 2000-10-19 Sloan-Kettering Institute For Cancer Research Methods and compositions for degradation and/or inhibition of her-family tyrosine kinases
EP1435939B1 (en) 2001-09-24 2008-02-27 Conforma Therapeutic Corporation Process for preparing 17-allyl amino geldanamycin (17-aag) and other ansamycins
EP1923061A1 (en) 2001-09-24 2008-05-21 Conforma Therapeutic Corporation Process for preparing 17-Allyl amino geldanamycin (17-AAG) and other ansamycins

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100796637B1 (ko) * 2006-09-29 2008-01-22 한국생명공학연구원 젤다나마이신 유도체, 이의 약학적으로 허용가능한 염,이의 제조방법 및 이를 유효성분으로 함유하는 암 예방 및치료제

Also Published As

Publication number Publication date
CN100378079C (zh) 2008-04-02
WO2003026571A2 (en) 2003-04-03
EP1435939A4 (en) 2004-12-29
US20050176695A1 (en) 2005-08-11
CN1558757A (zh) 2004-12-29
US7579462B2 (en) 2009-08-25
CA2460498A1 (en) 2003-04-03
DE60225307D1 (de) 2008-04-10
EP1435939A2 (en) 2004-07-14
EP1435939B1 (en) 2008-02-27
JP2005504086A (ja) 2005-02-10
DE60225307T2 (de) 2009-03-19
ATE387198T1 (de) 2008-03-15
WO2003026571A3 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
KR20040054692A (ko) 17-알릴 아미노 겔다나마이신 (17-ａａｇ) 및 기타안사마이신의 제조 방법
AU2013276138B2 (en) Multicomponent crystals comprising Dasatinib and selected cocrystal formers
CN114149476B (zh) 一种核糖核苷类似物的多晶型物、其制备方法及应用
EP3894407A1 (en) Process for preparing apixaban
EP3322709B1 (en) Crystalline forms of (3r)-3-cyclopentyl-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile salts and preparation thereof
EP3656768A1 (en) Beraprost-314d crystals and methods for preparation thereof
WO2012106584A2 (en) Pitavastatin salts
EP2688649B1 (en) A polymorph of lenalidomide
EP1923061A1 (en) Process for preparing 17-Allyl amino geldanamycin (17-AAG) and other ansamycins
CN114437076A (zh) 一种酮咯酸与异烟肼共晶及其制备方法
WO2013150544A2 (en) Ivabradine hydrochloride solid dispersion
AU2002326973A1 (en) Process for preparing 17-allyl amino geldanamycin (17-AAG) and other ansamycins
CN114380833A (zh) 一种酮咯酸与4-吡啶甲酰胺共晶及其制备方法
HK1120411A (en) Process for preparing 17-allyl amino geldanamycin (17-aag) and other ansamycins
WO2010146595A2 (en) Novel polymorphs of flibanserin hydrochloride
WO2016101412A1 (zh) 一种无结晶水二丁酰环磷腺苷钙晶型及其制备方法和应用
CZ20165A3 (cs) Způsoby přípravy amorfního apremilastu
US20110034686A1 (en) Process for Isolation and Purification of Geldanamycin
Chen et al. Design, synthesis and biological evaluation of novel potent STAT3 inhibitors based on related heterocycle-fused naphthoquinones for cancer therapy
EP3986864B1 (en) Recrystallisation of 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt) in methyl tert.-butyl ether (mtbe) without use of an aliphatic anti-solvent
WO2011055233A2 (en) Improved process for preparing celecoxib polymorph
US20050143431A1 (en) Novel crystalline forms of parecoxib sodium
CN112533894A (zh) 4,5-二羟基-2-(4-甲基苄基)异邻苯二甲腈溶剂化物及其结晶形式
CN101230040A (zh) 用于制备17-烯丙基氨基格尔德霉素(17-aag)以及其它袢霉素的方法
EP3636655A1 (en) Crystal form of fatty acid bile acid conjugate, method for preparing same, and application

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20040323

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20070821

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20081224

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20090615

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20081224

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I